Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Joseph Harvey

As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Simparica and Cytopoint surpass $100m, with another blockbuster in Zoetis' pipeline

Zoetis now has 12 blockbuster products in its portfolio and believes another one is on the way.

Zoetis R&D

Véronique Kodjo joins Ceva from Boehringer

Ceva Santé Animale has made two changes to its management team, as it prepares for its "next growth phase".

People Ceva Sante Animale

Phibro introduces new microbial for poultry gut optimization

Phibro Animal Health is bringing a new direct-fed microbial (DFM) to the US poultry market.

Phibro Animal Health Feed & Additives

Ongoing drivers at the heart of Zoetis Q4, best annual growth in over five years

Zoetis has reported a 7% increase in turnover for the fourth quarter of 2018, with its companion animal portfolio continuing to excel. 

Zoetis Financial Results

Evonik makes significant increase to venture capital war chest

Evonik Industries has introduced its second venture capital fund with a volume of €150 million ($169 million).

Investments M&A

LexaGene claims tech detects antibiotic-resistant canine urinary infections

US firm LexaGene claims its rapid canine pathogen detection technology can highlight the presence of antibiotic resistance factors.

Diagnostics Equipment & Technology
See All